t(3;21)(q26;q22) with AML1 rearrangement in a de novo childhood acute monoblastic leukaemia

被引:14
|
作者
Johansson, B
Fioretos, T
Garwicz, S
Heim, S
Mitelman, F
机构
[1] UNIV LUND HOSP,DEPT PAEDIAT,S-22185 LUND,SWEDEN
[2] NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT GENET,N-0310 MONTEBELLO,OSLO,NORWAY
关键词
childhood; acute leukaemia; translocation; AML1;
D O I
10.1046/j.1365-2141.1996.d01-1468.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
t(3;21)(q26;q22) is a recurrent chromosomal abnormality in Philadelphia-positive chronic myeloid leukaemia in blast crisis and in treatment-related myelodysplastic syndrome and acute myeloid leukaemia. The molecular consequences of the t(3;21) are presently being unravelled; various transcripts between the AML1 gene in 21q22 and several unrelated genes, i.e. EAP, EVI1 and MDS1, in 3q26 are generated, resulting in the formation of a chimaeric transcription factor. The t(3;21) has only rarely been described in de novo leukaemias and never before in an acute leukaemia in a child. We here present the clinical, cytogenetic and molecular genetic findings in a boy with a de novo acute monoblastic leukaemia with t(3;21)(q26;q22) and AML1 rearrangement.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 50 条
  • [1] Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22)
    Bacher, Ulrike
    Schnittger, Susanne
    Kern, Wolfgang
    Trenn, Guido
    Weisser, Martin
    Haferlach, Torsten
    Schoch, Claudia
    CANCER GENETICS AND CYTOGENETICS, 2006, 168 (02) : 172 - 174
  • [2] Translocation (3;21)(q26;q22) in de novo acute myelogenous leukemia
    Motomura, S
    Fujisawa, S
    Tsunooka, S
    Fujimaki, K
    Harano, H
    Mohri, H
    Okubo, T
    Fujita, H
    Maruta, A
    Kodama, F
    LEUKEMIA, 1997, 11 (01) : 172 - 173
  • [3] Translocation (3;21)(q26;q22) in de novo acute myelogenous leukemia
    S Motomura
    S Fujisawa
    S Tsunooka
    K Fujimaki
    H Harano
    H Mohri
    T Okubo
    H Fujita
    A Maruta
    F Kodama
    Leukemia, 1997, 11 : 172 - 173
  • [4] De novo AML M4Eo with t(3;21)(q26;q22) and AML-MDS/EVI-1 fusion transcript.
    Jost, E
    Michaux, L
    Sonet, A
    Chatelain, B
    Doyen, C
    Ferrant, A
    Vaerman, JL
    Bosly, A
    BLOOD, 1999, 94 (10) : 206B - 206B
  • [5] AML1 activation through t(3;21)(q26;q22): An aggressive syndrome of myeloid blast transformation following antimetabolite therapy
    Yin, CC
    Cortes, J
    Glassman, AB
    Valbuena, JR
    Hayes, K
    Kantarjian, H
    Jones, D
    LABORATORY INVESTIGATION, 2005, 85 : 259A - 259A
  • [6] AML1 activation through t(3;21)(q26;q22): An aggressive syndrome of myeloid blast transformation following anti metabolite therapy
    Yin, CC
    Cortes, J
    Glassman, AB
    Valbuena, JR
    Hayes, K
    Kantarjian, H
    Jones, D
    MODERN PATHOLOGY, 2005, 18 : 259A - 259A
  • [7] Human AML1/MDS1/EVI1 t(3;21)(q26;q22) fusion gene induces acute myelogenous leukemia in mice.
    Cuenco, GM
    Ren, R
    BLOOD, 1999, 94 (10) : 277A - 277A
  • [8] A primary pediatric acute myelomonocytic leukemia with t(3;21)(q26;q22): A case report
    Duan, Jia-xin
    Liu, Fang
    Chang, Li
    Che, Guang-lu
    Yang, Qiu-xia
    Teng, Jie
    Jian, Hui
    Liu, Xiao-juan
    Lai, Shu-yu
    MEDICINE, 2023, 102 (43) : E35721
  • [9] Unbalanced reciprocal translocation t(4;21)(q21;q22) in a "de novo" myelodysplastic syndrome resulting in AML1 loss
    Menezes, Juliane
    del Rio-Machin, Ana
    Ferreira, Bibiana
    Arribalzaga Juaristi, Karmele
    Alvarez, Sara
    Cigudosa, Juan C.
    CHROMOSOME RESEARCH, 2011, 19 : S140 - S140
  • [10] Molecular characterization of the genomic breakpoints in a case of t(3;21)(q26;q22)
    Hirai, H
    Ogawa, S
    Kurokawa, M
    Yazaki, Y
    Mitani, K
    GENES CHROMOSOMES & CANCER, 1999, 26 (01): : 92 - 96